Skip to main content
Preview

Research from Friday’s close · next update overnight after Monday’s close

Radar
NKE

NKE Research brief

Nike, Inc.

Adjusted close as of 2026-10-30
$38.67(+0.65%)

Sagehood’s view on NKE

Nike, Inc. · Research 2026-10-30 · Accepted

Research score

42Bearish50 is balancedScore unchanged since 2026-10-29 at 42; view unchanged at Bearish. Compare the two recordsConfidence 55 · It is not a calibrated probability of investment success.Confidence across the 100 names in this research run: 45 to 70, median 55.
How to read this score

Dated research brief

WhyThe bearish view is driven by a shrinking top line, since revenue fell 1.2% against a 5.0% sector median and quarterly growth slid to −4.3%. The unresolved risk is the peer-implied median of $44.83, which sits above the close.
What argues against this viewThe strongest case against the bearish view is the peer-implied valuation. The peer-implied median of $44.83 sits above the $38.67 close, and the stock holds 4.8% above its 50-day average, so the bounce may be more than a rally.
Break conditionA later reading showing trailing-twelve-month revenue growth at or above the 5.0% sector revenue-growth median would break the weak-growth claim.

Sagehood does not check this condition automatically. See research limitations below.

Valuation range

Close vs. model fair value · discounted cash flow

Bear
$7.40
Base
$16.80
Bull
$37.40

Base case −56% vs. the 2026-10-30 close, on fundamentals to 2026-08-31. Peer-implied median $44.83 from 3 peer-median multiples. Estimates from this research’s valuation model, not a price target.

The bear case sits more than 5× from the close: an extreme scenario, shown as the model computed it.

The market price implies more growth or higher margins than this model assumes, so its base case sits far below the close. The valuation specialist weighs that gap; it is not a forecast that the price will fall.

Against peers

Consumer Discretionary
MultipleNKEGroup medianPercentile
P/E (TTM)18.50×19.43×43rd
P/S1.25×1.45×44th
P/B3.77×5.20×38th
FCF yield3.67%3.08%67th
Score details & research limitations9 unavailable fields
Conditions Sagehood can check on its ownNot available in this run. A written break condition is not an automated check; this run does not provide a source-linked rule Sagehood can verify on its own.

How to read this research

The score expresses the published research view. 50 is balanced.

Bullish, Neutral or Bearish beside the score is the direction of that view, set by the research from the score: 65 and above is Bullish, 45 to 64 Neutral, 44 and below Bearish.

Confidence is how well the evidence supports this view, not which way it points: Sagehood research is asked to keep it no higher than its most confident specialist, and lower when the specialists disagree or much of the evidence is weak. It is not a calibrated probability of investment success.

Source verification checks the identity and origin of evidence. It does not prove that a claim is correct or that an investment will succeed.

Valuation estimates depend on their inputs and assumptions. They are not guaranteed future prices.

Retrospective research looks back at an earlier period. It is not a verified record of a decision made then using only information available then.

Unavailable is not zero. Read the adjacent reason: information may be missing, unverified or deliberately withheld.

How Sagehood works

The session this view is fixed to

Close$38.67 on 2026-10-30, as the research recorded it
Change on the day+0.65%
First eligible market session2026-11-02

Recorded score context

Specialist source coverage8 of 10 specialists have a verified source on this run. 2 do not.
Score reconciliationThe 8 specialist contributions shown add up to the weighted starting point this score was built from.
Change since the last accepted run42 on 2026-10-29 → 42 on 2026-10-30 (0 points). This is simple arithmetic between the two published scores, not an explanation of the change.
The run this is compared withResearch of 2026-10-29

Not in this run: Run-specific score definition, Confidence band, Horizon, Why the score changed, Today's unexplained move and Blockers.

What this was built from

Filing cited in the evidenceNot recorded on this card. The newest filing on record is under Key financials, and recent filings are listed under SEC filings.
Peer set9 names in Consumer Discretionary: AMZN, CCL, CMG, CVNA, F, NCLH, SBUX, TSCO, TSLA. How they were chosen is under “Valuation & peers”. The valuation range shows the peer-implied median from 3 peer-median multiples.

Not in this run: Company profile date and Standing disclosure.

Not available in this run

9 fields are unavailable. Each is identified with its reason above; missing information is not zero or a negative research signal.

Price context

· adjusted close $38.67

−4.4% from 2026-06-25

Recent price-basis check: 2026-10-02 to 2026-10-30 (20 sessions). Economic comparability outside this window remains unchecked.

NKE adjusted close
Adjusted price · USD · viewing 2026-06-25 to 2026-10-30

Selected 2026-10-30. NKE adjusted close. Continuous series. $38.67 US dollars.

90 daily adjusted-price observations through 2026-10-30, ending at the 2026-10-30 research date. The final point is a dated final close. Shown for context, not point-in-time research evidence: the research used the prices recorded with it.

Use the arrow keys on the chart to step through observations.

Published score history

2026-07-23 to 2026-10-30 · 37 publications

Each point is a verified published score. The line breaks where the research method changed (4 methods, numbered in the order they were first used), so scores are not joined across methods. Hollow points were published after their decision window (retrospective).

Every published score and confidence
Research dateScoreViewConfidenceMethod
2026-10-3042Bearish55Method 4
2026-10-2942Bearish49Method 4
2026-10-2844Bearish49Method 4
2026-10-2735Bearish49Method 4
2026-10-2642Bearish60Method 4
2026-10-2340Bearish55Method 4
2026-10-2240Bearish52Method 4
2026-10-2144Bearish50Method 4
2026-10-1636Bearish58Method 4
2026-10-0930Bearish65Method 4
2026-10-0730Bearish62Method 4
2026-10-0231Bearish60Method 4
2026-10-0134Bearish60Method 4
2026-09-3035Bearish72Method 4
2026-09-2935Bearish80Method 4
2026-09-2835Bearish80Method 4
2026-09-2535Bearish65Method 4
2026-09-24 · retrospective34Bearish66Method 4
2026-09-2335Bearish70Method 4
2026-09-1836Bearish65Method 4
2026-09-16 · retrospective35Bearish60Method 4
2026-09-09 · retrospective34Bearish65Method 4
2026-09-0438Bearish65Method 4
2026-09-01 · retrospective37Bearish75Method 4
2026-08-31 · retrospective41Bearish70Method 3
2026-08-2842Bearish70Method 3
2026-08-26 · retrospective42Bearish70Method 3
2026-08-24 · retrospective42Bearish70Method 3
2026-08-20 · retrospective42Bearish70Method 3
2026-08-19 · retrospective42Bearish70Method 3
2026-08-1441Bearish70Method 2
2026-08-1344Bearish70Method 1
2026-08-0743Bearish70Method 1
2026-08-0643Bearish70Method 1
2026-08-0443Bearish70Method 1
2026-07-3145Neutral62Method 1
2026-07-2342Bearish57Method 1

Specialists

8 of 10 published specialist analyses are available.

Each specialist’s view is shown as the published research recorded it; supporting detail appears only when it was recorded with that same view.

2 unavailable

NKE research

Financial specialist

Showing Financial specialist result.

Financial specialist

Evaluated for this session

Bearish

Nike's business is shrinking: trailing-twelve-month revenue of $45,891 million fell 1.2% year over year versus the 5.0% sector revenue-growth median, and quarterly growth slid to −4.3%. Free cash flow of $2,105 million and a 0.68 conversion ratio lag the 0.67 sector median only marginally.

Full analyst note

What the specialist sees

Evidence: trailing-twelve-month revenue of $45,891 million fell 1.2% year over year against the 5.0% sector revenue-growth median, and quarterly revenue growth decelerated from 0.6% to −4.3% over the last four quarters.

Why it matters now

Persistent negative revenue growth alongside decelerating quarterly trends implies the business is losing top-line momentum, which pressures earnings and cash generation if the trend continues.

What could change the view

Countercase: The read would be wrong if the next filing shows revenue growth recovering above the 5.0% sector revenue-growth median or if free cash flow conversion rebounds above the 0.67 sector median, since both would signal the decline is stabilizing rather than persisting. Falsifier: A later reading showing trailing-twelve-month revenue growth at or above the 5.0% sector revenue-growth median would break the weak-growth claim.

Specialist score details
Specialist score
44
Evidence confidence
70
Base weight for this role
0.13
Base weight × confidence
9.10
Weight in the score (the chip's weight)
0.20
Weighted contribution
8.66
Business driver
Trailing-twelve-month revenue of $45,891 million fell 1.2% year over year against the 5.0% sector revenue-growth median, and quarterly revenue growth decelerated from 0.6% to −4.3% over the last four quarters.
Mechanism
Persistent negative revenue growth alongside decelerating quarterly trends implies the business is losing top-line momentum, which pressures earnings and cash generation if the trend continues.
Countercase
The read would be wrong if the next filing shows revenue growth recovering above the 5.0% sector revenue-growth median or if free cash flow conversion rebounds above the 0.67 sector median, since both would signal the decline is stabilizing rather than persisting.
Contributions & coverage details

Specialist contributions

Each specialist’s recorded numbers, in the usual specialist order, as recorded: nothing is re-ranked or recalculated. Weights and contributions show two decimals; hover for the exact value.

Financial specialist

Bearish

Score
44
Evidence confidence
70
Weight in the score
0.20
Weighted contribution
8.66

Risk specialist

Bearish

Score
42
Evidence confidence
55
Weight in the score
0.10
Weighted contribution
4.00

Sector specialist

Bearish

Score
42
Evidence confidence
55
Weight in the score
0.12
Weighted contribution
5.00

SEC filings specialist

Neutral

Score
50
Evidence confidence
55
Weight in the score
0.04
Weighted contribution
1.78

News specialist

Neutral

Score
48
Evidence confidence
38
Weight in the score
0.09
Weighted contribution
4.34

Price-trend specialist

Neutral

Score
48
Evidence confidence
55
Weight in the score
0.24
Weighted contribution
11.42

Valuation specialist

Bearish

Score
30
Evidence confidence
35
Weight in the score
0.12
Weighted contribution
3.63

Economy specialist

Neutral

Score
50
Evidence confidence
60
Weight in the score
0.10
Weighted contribution
5.19

Published specialist analyses unavailable: Geopolitics specialist, Social-media specialist. No specialist result is inferred.

  • Geopolitics specialist: This specialist had no checked public source on this run, so no source-backed analysis is shown.
  • Social-media specialist: This specialist had no checked public source on this run, so no source-backed analysis is shown.

How this insight was formed

Each specialist view shown here is checked against the published research files. Sagehood research combined those views into the one Research Score above.

Evidence & method

Inspect the reasoning, source records and valuation behind this dated view.

Sagehood research reasoningSpecialist reasoning, selected statements and filing context
Accepted publication2026-10-30 researchNext eligible session 2026-11-02point-in-time

NKE: Sagehood research reasoning

Accepted research score

42

Bearish50 is balanced
Lead specialist in the research decision:

Financial specialist

Bearish

Specialist score 44Evidence confidence 70
What the specialist sees

Trailing-twelve-month revenue of $45,891 million fell 1.2% year over year against the 5.0% sector revenue-growth median, and quarterly revenue growth decelerated from 0.6% to −4.3% over the last four quarters.

Why it matters

Persistent negative revenue growth alongside decelerating quarterly trends implies the business is losing top-line momentum, which pressures earnings and cash generation if the trend continues.

What argues against it

The read would be wrong if the next filing shows revenue growth recovering above the 5.0% sector revenue-growth median or if free cash flow conversion rebounds above the 0.67 sector median, since both would signal the decline is stabilizing rather than persisting.

This specialist’s break condition: A later reading showing trailing-twelve-month revenue growth at or above the 5.0% sector revenue-growth median would break the weak-growth claim.

How the score was formed

The specialists’ weighted starting point was 44.03. Sagehood research’s adjustment was −2.03. 42 on 2026-10-29 → 42 on 2026-10-30 (0 points). This is simple arithmetic between the two published scores, not an explanation of the change.

Evidence Sagehood research weighed

These selected claims are evidence Sagehood research weighed, not a reconstruction of the numeric adjustment.

Claims as this research published them. Sagehood confirms each claim and its support were published together with this research. That is not an independent check, and it does not prove the claim is accurate or predict future performance.

  1. Financial specialist

    Same statement as under “What the specialist sees” above.

  2. Valuation specialist

    The base case pairs revenue growth of −2.6% with an FCF margin of 4.6% for a fair value of $16.8, while the close is $38.67 and the peer-implied median of $44.83 rests on 3 implied prices.

  3. Price-trend specialist

    Close 38.67 sits 4.8% above 50-day average and 14.8% below 200-day average, with the 1-year log channel at −48.9% per year (fit R² 0.88) and trend-channel position 1.76 standard deviations; 14-day RSI is 61.9 while 14-week RSI is 42.9.

Sagehood research decision

The investment case, main risk and break condition are the ones shown under Sagehood’s view at the top of this page.

Recorded break condition
Break condition as kept in the decision trail

A later reading showing TTM revenue growth at or above the 5.0% sector revenue-growth median would break the weak-growth claim.

Evidence & sourcesClaim-support availability, filing-context links and research method

NKE: This run has no checked links from its claims to their evidence. The specialists’ writing is shown as recorded, and no missing evidence is filled in.

Accepted research

Research dated 2026-10-30.

How this research was made

This research is AI-generated and is not investment advice.

Research date
2026-10-30
Valuation & peersInput limits notedFair-value cells, peer multiples and the inputs behind the range

Valuation the research computed

Against the 2026-10-30 close of $38.67 (recorded)

Fundamentals reference date: 2026-08-31.

Fair value by discounted cash flow, at the cells this run nominated.

Bear
$7.40−81% vs close
Base
$16.80−56% vs close
Bull
$37.40−3% vs close

The bear case sits more than 5× from the close: an extreme scenario, shown as the model computed it.

Implied by the median of 3 peer-median multiples: $44.83 (+15.9% vs close)

Peers: the 9 Liquid 100 names in Consumer Discretionary that this run priced. Companies outside the Liquid 100 are not in the set.

The names: AMZN, CCL, CMG, CVNA, F, NCLH, SBUX, TSCO, TSLA.

Multiples against the peer group

Consumer Discretionary · 9 companies in the group

  • Price to earnings (trailing twelve months)18.50×

    Peer median 19.43× · middle half 15.19× to 44.69× · 43rd percentile of the group

  • Price to sales1.25×

    Peer median 1.45× · middle half 0.97× to 3.27× · 44th percentile of the group

  • Price to book3.77×

    Peer median 5.20× · middle half 2.77× to 9.07× · 38th percentile of the group

  • Free cash flow yield3.67%

    Peer median 3.08% · middle half 0.23% to 4.17% · 67th percentile of the group

This run declares Enterprise value to EBITDA and computes no value for it, for this company or for its peer group.

Evidence limits: 8 valuation inputs required conservative handling: another valuation input required conservative handling; no full-year operating income was filed; no full-year shares-outstanding figure was filed; depreciation and amortization were available but not used because this version does not compute an EV/EBITDA multiple.

Includes the currently displayed specialist or comparison, not every specialist. Dates and limitations remain attached.

Sagehood research is for general information. It is not individualized investment advice or a recommendation to buy or sell any security.

Nike, Inc. (NKE) research | Sagehood